Caixin
Aug 19, 2022 08:00 AM

Anhui Huaheng Biotechnology Co.,Ltd.’s Net Profit Rose 107.6% in First Half of 2022

Anhui Huaheng Biotechnology Co.,Ltd. (安徽华恒生物科技股份有限公司) (688639.SH) reported a net profit of 129 million yuan in the first half of 2022, up 107.6% year-on-year.

Meanwhile, the company posted 628.9 million yuan in revenue, up 65.7% year-on-year.

At the end of the reporting period, it had 1.7 billion yuan in total assets and 418.7 million yuan in total liabilities, with a liability-to-asset ratio of 24.8%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
Caixin Deep Dive: Why Singapore Sovereign Fund Sues Chinese EV-Maker Nio
00:00
00:00/00:00